Pages that link to "Q49025036"
Jump to navigation
Jump to search
The following pages link to Adalimumab in Patients with Active Noninfectious Uveitis. (Q49025036):
Displaying 50 items.
- Red Eye: A Guide for Non-specialists (Q30355104) (← links)
- Recent advances in managing and understanding uveitis. (Q37709700) (← links)
- Development of an activity disease score in patients with uveitis (UVEDAI). (Q37709990) (← links)
- Not all TNF inhibitors in rheumatoid arthritis are created equal: important clinical differences (Q38673326) (← links)
- Management of severe complications in Behçet's disease with TNF inhibitors. (Q38786414) (← links)
- Adalimumab for the treatment of uveitis (Q39111626) (← links)
- Adalimumab: A Review in Non-Infectious Non-Anterior Uveitis (Q39147540) (← links)
- Ocular sarcoidosis: new diagnostic modalities and treatment (Q39378564) (← links)
- IL-6 blockade in the management of non-infectious uveitis (Q40204739) (← links)
- Vision-related Quality of Life in Patients with Non-infectious Uveitis: A Cross-sectional Study (Q40286043) (← links)
- Effect of Adalimumab on Peripheral Blood Mononuclear Cells in Non-Infectious Uveitis (Q41986970) (← links)
- An Update on Treatment of Pediatric Chronic Non-Infectious Uveitis (Q41994612) (← links)
- Augmenting Endogenous Levels of Retinal Annexin A1 Suppresses Uveitis in Mice (Q43270658) (← links)
- Oxidative stress and reactive oxygen species: a review of their role in ocular disease (Q46248374) (← links)
- Dexamethasone implants in paediatric patients with noninfectious intermediate or posterior uveitis: first prospective exploratory case series. (Q47143608) (← links)
- Immunosuppression for the Uveitides (Q47932596) (← links)
- Adalimumab in refractory cystoid macular edema associated with birdshot chorioretinopathy (Q48288484) (← links)
- Tocilizumab for the treatment of birdshot uveitis that failed interferon alpha and anti-tumor necrosis factor-alpha therapy: two cases report and literature review (Q49350278) (← links)
- A Review of the Landscape of Targeted Immunomodulatory Therapies for Non-Infectious Uveitis (Q49490534) (← links)
- Randomized Controlled Study to Evaluate the Efficacy of Adalimumab in Patients with Different Forms of Refractory Uveitis (Q49494558) (← links)
- DOG and BVA guideline no. 24b : Noninfectious uveitis posterior (Q49845401) (← links)
- Impact of red and processed meat and fibre intake on treatment outcomes among patients with chronic inflammatory diseases: protocol for a prospective cohort study of prognostic factors and personalised medicine. (Q50036719) (← links)
- Distinguishing Uveitis Secondary to Sarcoidosis From Idiopathic Disease: Cardiac Implications (Q50074136) (← links)
- Ocular, Auricular, and Oral Manifestations of Inflammatory Bowel Disease (Q50075113) (← links)
- Intravitreal Adalimumab for the Control of Breakthrough Intraocular Inflammation (Q50091416) (← links)
- Management of chronic ocular sarcoidosis: challenges and solutions (Q52338865) (← links)
- Platelet-Activating Factor (PAF) Receptor Antagonism Modulates Inflammatory Signaling in Experimental Uveitis (Q52593966) (← links)
- Cytokines in uveitis. (Q52664758) (← links)
- Effects of Vedolizumab Therapy on Extraintestinal Manifestations in Inflammatory Bowel Disease. (Q55441867) (← links)
- Recommendation of using systemic anti-tumor necrosis factor-alpha for the treatment of noninfectious uveitis in Taiwan (Q57193056) (← links)
- Biologics for the treatment of noninfectious uveitis (Q57193060) (← links)
- Noninfectious uveitis in the Asia-Pacific region (Q57462698) (← links)
- Reclassifying Idiopathic Uveitis: Lessons from a Tertiary Uveitis Center (Q57807256) (← links)
- Long-term retention rates of adalimumab and infliximab in non-infectious intermediate, posterior, and panuveitis (Q58325886) (← links)
- The Management of Acute Anterior Uveitis Complicating Spondyloarthritis: Present and Future (Q58567074) (← links)
- Outcomes of non-infectious Paediatric uveitis in the era of biologic therapy (Q58799412) (← links)
- The use of biologic therapies in uveitis (Q59352828) (← links)
- Tofacitinib for refractory uveitis and scleritis (Q60308037) (← links)
- Effective treatment of refractory sympathetic ophthalmia with glaucoma using adalimumab (Q61808799) (← links)
- Pharmacokinetics, Safety, and Tolerability of the Dual Inhibitor of Tumor Necrosis Factor-α and Interleukin 17A, ABBV-257, in Healthy Volunteers and Patients With Rheumatoid Arthritis (Q62633601) (← links)
- [Registry-based research in ophthalmology] (Q64045475) (← links)
- Adalimumab Accounts for Long-Term Control of Noninfectious Uveitis Also in the Absence of Concomitant DMARD Treatment: A Multicenter Retrospective Study (Q64226490) (← links)
- Comparative efficacy of steroid-sparing therapies for non-infectious uveitis. (Q64910333) (← links)
- Anti-TNF Drugs for Chronic Uveitis in Adults-A Systematic Review and Meta-Analysis of Randomized Controlled Trials. (Q64937305) (← links)
- Serpiginoid choroiditis associated with presumed ocular tuberculosis. (Q64946439) (← links)
- The Eyes Have it: A Rheumatologist's View of Uveitis (Q88781061) (← links)
- Optimising drug therapy for non-infectious uveitis (Q89366267) (← links)
- A Case of Recurrent Vogt-Koyanagi-Harada Disease Successfully Treated with Adalimumab in Young Female Adult Patient (Q89618020) (← links)
- Intraocular Inflammation Control and Changes in Retinal and Choroidal Architecture in Refractory Non-Infectious Uveitis Patients after Adalimumab Therapy (Q89761641) (← links)
- Effect of Corticosteroid-Sparing Treatment With Mycophenolate Mofetil vs Methotrexate on Inflammation in Patients With Uveitis: A Randomized Clinical Trial (Q90018532) (← links)